翻译硕士考研要看的知识较广，考生们复习不能局限于书本内容，还需看中国日报上的信息。接下来，北京文都考研网为帮助2021翻译硕士考生及时掌握中国日报中的热词，特意整理——2021考研MTI中国日报3月热词:重组冠状病毒疫苗Ⅰ期试验，供考生参考。
2021考研MTI中国日报3月热词:重组冠状病毒疫苗Ⅰ期试验
我国展开新冠肺炎疫苗Ⅰ期临床试验，周末志愿者参与该项目的照片和视频开始在社交媒体上流传。
相关报道：
The phase 1 clinical trial for recombinant novel coronavirus vaccine was registered on March 17. according to the Chinese Clinical Trial Registry. The COVID-19 vaccine was jointly developed by the Institute of Biotechnology, the Academy of Military Medical Sciences of the People's Liberation Army, and Tianjin-based CanSino Biologics Inc.
根据中国临床试验注册中心消息，重组新型冠状病毒疫苗Ⅰ期临床试验于本月17日注册通过，由军事科学院军事医学研究院和天津的康希诺生物股份公司联合研发。
The trial is being conducted on 108 healthy adults ages 18 to 60 in two medical facilities in Wuhan, Hubei province.
试验在湖北武汉两家医疗机构里108名年龄为18-60岁的健康的成年人中展开。
The trial is expected to be completed by Dec 31. according to the registry.
注册信息显示，试验将于12月31日前完成。
As a subunit vaccine, it contains only a fragment of the pathogen to stimulate a protective immune response.
该疫苗为亚单位疫苗，只含有刺激保护性免疫反应的病原体片段。
The volunteers will receive a series of follow-up examinations in the six months after being injected to see if their bodies have generated an antibody to the virus.
未来半年里，接种疫苗的志愿者将接受一系列的后续检查，以观察他们的身体是否产生对抗病毒的抗体。
以上是北京文都考研网分享的——2021考研MTI中国日报3月热词:重组冠状病毒疫苗Ⅰ期试验，希望对2021翻译硕士考研者们，在学习上面有所帮助!祝2021考研金榜题名!
推荐阅读：
![京网文[2014]2116-316号](https://bj.wendu.com/imgs/jingicp.jpg){kind=link}
